Schedule 13D ownership disclosure

Prime Medicine Inc

Security class unavailable · CUSIP: 74168J101

Event date: 2024-02-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-24-000265
Form type
SC 13D
Filer
ARCH Venture Fund XII, L.P.
CIK
CIK 1906837
Filed
Feb 22, 2024
Reporting period
Feb 15, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub